Glenview Trust Co Takes $5.77 Million Position in Cigna Group $CI

Key Points

• Glenview Trust Co. acquired 20,914 shares of Cigna in the second quarter, representing a position valued at approximately $5.77 million. Institutional investors collectively own 86.99% of the company.
• Analysts remain broadly positive, with 15 Buy ratings and seven Holds producing a “Moderate Buy” consensus and an average price target of $339.45.
• Cigna exceeded quarterly earnings expectations, reporting $7.78 in adjusted EPS and $70.04 billion in revenue, while revenue grew 6.7% year over year. The company also declared a quarterly dividend of $1.56 per share, yielding about 2.3% annually.

Glenview Trust Co acquired a new stake in Cigna Group (NYSE:CI - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 20,914 shares of the health services provider's stock, valued at approximately $5,766,000.

Several other large investors have also bought and sold shares of CI. Brighton Jones LLC boosted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 318 shares in the last quarter. Sivia Capital Partners LLC grew its stake in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider's stock worth $384,000 after purchasing an additional 109 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Cigna Group by 4.5% in the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider's stock worth $7,347,000 after purchasing an additional 958 shares in the last quarter. Treasurer of the State of North Carolina lifted its stake in Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider's stock valued at $49,204,000 after purchasing an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. acquired a new stake in Cigna Group during the second quarter valued at approximately $163,000. Institutional investors own 86.99% of the company's stock.

Wall Street Analysts Forecast Growth

CI has been the topic of several recent research reports. Sanford C. Bernstein lifted their price target on shares of Cigna Group from $371.00 to $381.00 and gave the stock an "outperform" rating in a research report on Thursday, July 9th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a "buy" rating to a "hold" rating and cut their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Morgan Stanley raised their price objective on Cigna Group from $355.00 to $361.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 20th. The Goldman Sachs Group lifted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a "buy" rating in a report on Monday, May 4th. Finally, Guggenheim boosted their target price on Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, Cigna Group presently has an average rating of "Moderate Buy" and a consensus price target of $339.45.

Cigna Group Stock Performance

CI stock opened at $277.21 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The stock has a market cap of $73.25 billion, a P/E ratio of 11.47, a P/E/G ratio of 0.97 and a beta of 0.29. The firm has a 50 day simple moving average of $283.53 and a 200 day simple moving average of $281.41. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same quarter in the prior year, the business earned $7.20 EPS. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group's dividend payout ratio is 25.82%.

Insiders Place Their Bets

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the company's stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 23,012 shares of company stock worth $6,386,550 over the last ninety days. 0.60% of the stock is currently owned by company insiders.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source